vision

Health Tech By Casey Ross

Google develops AI to identify patients at high risk of blindness

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Pharmalot By Ed Silverman

Novartis employee claims she was fired for complaining about incorrect data

Biotech By Matthew Herper

Safety concerns regarding Novartis’ new eye drug boost Regeneron stock

Health Tech By Lauren Joseph

5 burning questions about using artificial intelligence to prevent blindness

Biotech By Robert Weisman — Boston Globe

Research into new macular degeneration treatments takes off as cases steadily rise

In the Lab By Casey Ross

Opening the ‘black box,’ Google DeepMind AI system diagnoses eye diseases and shows its work

In the Lab By Orly Nadell Farber

Glaucoma may be an autoimmune disease, study finds, suggesting new treatment approaches

In the Lab By Andrew Joseph

Early trials of stem-cell therapies hint at potential to restore some vision

In the Lab By Sharon Begley

A CRISPR trick in blind mice points the way to possible treatments for inherited diseases

Biotech By Andrew Joseph

At $850,000, price for new childhood blindness gene therapy four times too high, analysis says

Health By Rebecca Robbins

‘What the 21st century demands’: designing homes to improve patients’ health

Health By Leah Samuel

5 beauty-enhancing gadgets throughout history that were terrible ideas

Health By Charles Piller

Google Glass is back — as a tool to coach autistic children, train doctors, and more

Medical Mystery By Allison Bond

This 6-year-old suddenly had trouble reading. Why was she going blind?

In the Lab By Andrew Joseph

Q&A: Turning to stem cells to restore vision

In the Lab By Eric Boodman

Transplanted eyes let tadpoles see through their tails

Health By Associated Press

New help for that bane of middle age: blurry close-up vision

Business By Charles Piller

Autofocus contact lens being developed by Verily and Alcon suffers delay